title: Postpartum thrombosis after a successful pregnancy in a recurrent aborter strongly positive for antiphospholipid antibodies.
authors.affiliation: Department of Obstetrics & Gynecology, Nagoya City University Medical School, Nagoya, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Katano
authors.forename: K
authors.initials: K
authors.lastname: Aoki
authors.forename: M
authors.initials: M
authors.lastname: Ogasawara
authors.forename: T
authors.initials: T
authors.lastname: Aoyama
authors.forename: K
authors.initials: K
authors.lastname: Suzumori
mesh_terms: D000026:Abortion, Habitual / Q000209:etiology / Q000517:prevention & control*; D000328:Adult; D017152:Antibodies, Antiphospholipid / Q000097:blood* / Q000187:drug effects; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D011247:Pregnancy; D011256:Pregnancy Outcome; D011644:Puerperal Disorders / Q000097:blood / Q000209:etiology* / Q000503:physiopathology; D013924:Thrombophlebitis / Q000097:blood / Q000209:etiology* / Q000503:physiopathology
chemical_list: D017152:Antibodies, Antiphospholipid; D000925:Anticoagulants; D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D011239:Prednisolone; D001241:Aspirin